Oncology & Cancer

Blood clue to prostate cancer recurrence

Men with blood group O are far less likely to suffer a recurrence of cancer after prostate tumour surgery than men with other blood types, researchers reported on Monday.

Oncology & Cancer

Added prostate CA criteria may help ID surveillance candidates

(HealthDay)—Additional predictors, such as prostate-specific antigen (PSA) density and extent of cancer on biopsy, help guide selection of prostate cancer patients for active surveillance programs, according to research ...

Oncology & Cancer

A rise in early diagnosis of prostate cancer

(Medical Xpress)—Over the last two decades, incremental gains have been made in the number of men given early diagnosis of prostate cancer, and the way they are treated, a Victorian study found.

Oncology & Cancer

Surgeon variation affects QoL after prostatectomy

(HealthDay)—There is a significant association between performing surgeons and patient quality of life following radical prostatectomy, according to a study published in the April issue of The Journal of Urology.

Surgery

Similar outcomes for robotic, laparoscopic prostatectomy

(HealthDay)—For men undergoing routine surgical treatment for localized cancer of the prostate, robot-assisted radical prostatectomy (RALP) does not result in better functional outcomes compared to laparoscopic radical ...

page 8 from 12